Oruka Therapeutics, Inc. — SC 13D/A Filings
12 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Oruka Therapeutics, Inc. (ORKA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Oruka Therapeutics, Inc. has filed 12 SC 13D/A documents with the SEC since 2008. To view all SEC filings by Oruka Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 0001213900-24-101117 | Nov 21, 2024 | — |
| SC 13D/A | — | 0000902664-24-005943 | Oct 22, 2024 | — |
| SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0001213900-24-078635 | Sep 13, 2024 | — |
| SC 13D/A | AMENDMENT NO. 6 TO THE SCHEDULE 13D | 0000921895-22-002198 | Jul 8, 2022 | — |
| SC 13D/A | AMENDMENT NO. 5 TO THE SCHEDULE 13D | 0000921895-22-002046 | Jun 21, 2022 | — |
| SC 13D/A | AMENDMENT NO. 4 TO THE SCHEDULE 13D | 0000921895-22-001819 | May 27, 2022 | — |
| SC 13D/A | AMENDMENT NO. 3 TO THE SCHEDULE 13D | 0000921895-22-001583 | May 11, 2022 | — |
| SC 13D/A | AMENDMENT NO. 2 TO THE SCHEDULE 13D | 0000921895-22-001251 | Apr 14, 2022 | — |
| SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-22-001068 | Apr 4, 2022 | — |
| SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- ARCA BIOPHARMA, INC. - SCHEDULE 13D | 0001072613-18-000184 | Mar 5, 2018 | — |
| SC 13D/A | — | 0000903423-06-000286 | Mar 15, 2006 | — |
| SC 13D/A | SCHEDULE 13D AMENDMENT | 0001086144-00-000033 | Apr 13, 2000 | — |